Drug induced liver injury screening: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) Created page with "__NOTOC__ {{Drug induced liver injury}} {{CMG}} {{AE}} ==Overview== ==Screening== ==References== {{Reflist|2}} Category:Hepatology" |
mNo edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Drug induced liver injury}} | {{Drug induced liver injury}} | ||
{{CMG}} {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
==Screening== | ==Screening== | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Hepatology]] | [[Category:Hepatology]] |
Revision as of 13:55, 3 August 2016
Drug induced liver injury Microchapters |
Differentiating Drug Induced Liver Injury from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Drug Induced Liver Injury On the Web |
American Roentgen Ray Society Images of Drug induced liver injury |
Risk calculators and risk factors for Drug induced liver injury |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: